>> 全站文章索引 >> 第8页:
Neuropsychologic symptoms in obstructive sleep apnea improve after treatment with nasal continuous positive airway pressure - [SS Derderian, RH Bridenbaugh and KR Rajagopal]
Impact of Antidepressant Discontinuation After Acute Bipolar Depression Remission on Rates of Depressive Relapse at 1-Year Follow-Up - [Lori Altshuler, M.D., Trisha Suppes, M.D., Ph.D., David Black, M.A., Willem A. Nolen, M.D., Ph.D., Paul E. Keck, Jr., M.D., Mark A. Frye, M.D., Susan McElroy, M.D., Ralph Kupka, M.D., Heinz Grunze, M.D., J?rg Walden, M.D., Ph.D., Gabrielle Leverich, M.S.W]
Fatigue in Obstructive Sleep Apnea: Driven by Depressive Symptoms Instead of Apnea Severity? - [Wayne A. Bardwell, Ph.D., Polly Moore, Ph.D., Sonia Ancoli-Israel, Ph.D. and Joel E. Dimsdale, M.D.]
A polysomnographic and clinical report on sleep-related injury in 100 adult patients - [Steve Joncas, BSc, Antonio Zadra, PhD, Jean Paquet, PhD and Jacques Montplaisir, MD PhD, CRCPc]
The value of sleep deprivation as a diagnostic tool in adult sleepwalkers - [Roger J. Broughton]
Sleepwalking Violence: A Sleep Disorder, a Legal Dilemma, and a Psychological Challenge - [Rosalind Cartwright, Ph.D.]
Insomnia in Young Men and Subsequent Depression - [Patricia P. Chang1,, Daniel E. Ford1,2,3, Lucy A. Mead1, Lisa Cooper-Patrick1,2 and Michael J. Klag]
Sleep Disturbance and Risk for Alcohol-Related Problems - [Rosa M. Crum, M.D., M.H.S., Carla L. Storr, Sc.D., Ya-Fen Chan, M.S.N. and Daniel E. Ford, M.D., M.P.H.]
Prediction of Antidepressant Effects of Sleep Deprivation by Metabolic Rates in the Ventral Anterior Cingulate and Medial Prefrontal Cortex - [Joseph Wu, M.D., Monte S. Buchsbaum, M.D., J. Christian Gillin, M.D., Cheuk Tang, M.S., Stephanie Cadwell, B.A., Michael Wiegand, M.D., Ahmad Najafi, Ph.D., Eric Klein, B.S., Kaye Hazen, B.S. and William E. Bunney, Jr., M.D.]
Neurobiology of Non-REM Sleep in Depression: Further Evidence for Hypofrontality and Thalamic Dysregulation - [Anne Germain, Ph.D., Eric A. Nofzinger, M.D., David J. Kupfer, M.D. and Daniel J. Buysse, M.D.]
REM Sleep and the Early Development of Posttraumatic Stress Disorder - [Thomas A. Mellman, M.D., Victoria Bustamante, Psy.D., Ana I. Fins, Ph.D., Wilfred R. Pigeon, Ph.D. and Bruce Nolan, M.D.]
Sleep Complaints and Depression in an Aging Cohort: A Prospective Perspective - [Robert E. Roberts, Ph.D., Sarah J. Shema, M.S., George A. Kaplan, Ph.D. and William J. Strawbridge, Ph.D.]
Sleep-Related Functioning in Euthymic Patients With Bipolar Disorder, Patients With Insomnia, and Subjects Without Sleep Problems - [Allison G. Harvey, Ph.D., D. Anne Schmidt, B.A., Antonina Scarnà, Ph.D., Christina Neitzert Semler, D.Phil. And Guy M. Goodwin, F.R.C.Psych.]
Cognitive Behavior Therapy and Paroxetine in the Treatment of Hypochondriasis: A Randomized Controlled Trial - [Anja Greeven, M.Sc., Anton J.L.M. van Balkom, M.D., Ph.D., Sako Visser, Ph.D., Jille W. Merkelbach, M.D., Yanda R. van Rood, Ph.D., Richard van Dyck, M.D., Ph.D., A.J. Willem Van der Does, Ph.D., Frans G. Zitman, M.D., Ph.D. and Philip Spinhoven, Ph.D.]
Treatment of Acute Posttraumatic Stress Disorder With Brief Cognitive Behavioral Therapy: A Randomized Controlled Trial - [Marit Sijbrandij, M.A., Miranda Olff, Ph.D., Johannes B. Reitsma, M.D., Ph.D., Ingrid V.E. Carlier, Ph.D., Mirjam H. de Vries, M.A. and Berthold P.R. Gersons, M.D., Ph.D.]
A Randomized, Controlled Trial With 6-Month Follow-Up of Repetitive Transcranial Magnetic Stimulation and Electroconvulsive Therapy for Severe Depression - [Savitha Eranti, M.D., M.R.C.Psych., Andrew Mogg, M.R.C.Psych., Graham Pluck, Ph.D., Sabine Landau, Ph.D., Rick Purvis, B.Sc., Richard G. Brown, Ph.D., Robert Howard, M.D., M.R.C.Psych., Martin Knapp, Ph.D., Michael Philpot, F.R.C.Psych., Sophia Rabe-Heske]
Psychiatric Disorders Among Survivors of the Oklahoma City Bombing - [Carol S. North, MD, MPE; Sara Jo Nixon, PhD; Sheryll Shariat, MPH; Sue Mallonee, RN, MPH; J. Curtis McMillen, PhD; Edward L. Spitznagel, PhD; Elizabeth M. Smith, PhD]
Psychosocial Intervention for Postdisaster Trauma Symptoms in Elementary School Children - [Claude M. Chemtob, PhD; Joanne P. Nakashima, Med; Roger S. Hamada, PhD]
Risk-Taking Behaviors Among Israeli Adolescents Exposed to Recurrent Terrorism: Provoking Danger Under Continuous Threat? - [Ruth Pat-Horenczyk, Ph.D., Osnat Peled, M.A., Tomer Miron, M.A., Daniel Brom, Ph.D., Yael Villa, Ph.D. and Claude M. Chemtob, Ph.D.]
Independent Domains of Inhibitory Gating in Schizophrenia and the Effect of Stimulus Interval - [L. Elliot Hong, M.D., Ann Summerfelt, M.A., Ikwunga Wonodi, M.D., Helene Adami, M.S.W., Robert W. Buchanan, M.D. and Gunvant K. Thaker, M.D.]
Service Costs of Caring for Adolescents With Mental Illness in a Rural Community, 1993–2000 - [E. Jane Costello, Ph.D., William Copeland, Ph.D., Alexander Cowell, Ph.D. and Gordon Keeler, M.S.]
A Placebo-Controlled Evaluation of Adjunctive Modafinil in the Treatment of Bipolar Depression - [Mark A. Frye, M.D., Heinz Grunze, M.D., Trisha Suppes, M.D., Ph.D., Susan L. McElroy, M.D., Paul E. Keck Jr., M.D., Jorge Walden, M.D., Gabriele S. Leverich, M.S.W., L.C.S.W.-C., Lori L. Altshuler, M.D., Shoshanna Nakelsky, M.P.H., Sun Hwang, M.S., Jim Mi]
Parental Diagnoses in Youth With Narrow Phenotype Bipolar Disorder or Severe Mood Dysregulation - [Melissa A. Brotman, Ph.D., Layla Kassem, Ph.D., Michelle M. Reising, B.A., Amanda E. Guyer, Ph.D., Daniel P. Dickstein, M.D., Brendan A. Rich, Ph.D., Kenneth E. Towbin, M.D., Daniel S. Pine, M.D., Francis J. McMahon, M.D. and Ellen Leibenluft, M.D.]
Pharmacogenetics of Antidepressant Medication Intolerance - [Greer M. Murphy, Jr., M.D., Ph.D., Charlotte Kremer, M.D., Heidi E. Rodrigues, B.A. and Alan F. Schatzberg, M.D.]
Tranylcypromine Versus Venlafaxine Plus Mirtazapine Following Three Failed Antidepressant Medication Trials for Depression: A STAR*D Report - [Patrick J. McGrath, M.D., Jonathan W. Stewart, M.D., Maurizio Fava, M.D., Madhukar H. Trivedi, M.D., Stephen R. Wisniewski, Ph.D., Andrew A. Nierenberg, M.D., Michael E. Thase, M.D., Lori Davis, M.D., Melanie M. Biggs, Ph.D., Kathy Shores-Wilson, Ph.D., J]
Mirtazapine for PTSD Nightmares - [JONATHAN D. LEWIS, M.D.]
A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A STAR*D Report - [Maurizio Fava, M.D., A. John Rush, M.D., Stephen R. Wisniewski, Ph.D., Andrew A. Nierenberg, M.D., Jonathan E. Alpert, M.D., Ph.D., Patrick J. McGrath, M.D., Michael E. Thase, M.D., Diane Warden, Ph.D., M.B.A., Melanie Biggs, Ph.D., James F. Luther, M.A.,]
Association of GRIK4 With Outcome of Antidepressant Treatment in the STAR*D Cohort - [Silvia Paddock, Ph.D., Gonzalo Laje, M.D., Dennis Charney, M.D., A. John Rush, M.D., Alexander F. Wilson, Ph.D., Alexa J.M. Sorant, M.A., Robert Lipsky, Ph.D., Stephen R. Wisniewski, Ph.D., Husseini Manji, M.D. and Francis J. McMahon, M.D.]
Antenatal Depression: Navigating the Treatment Dilemmas - [Marlene P. Freeman, M.D.]
Effects of physical exercise on depression, neuroendocrine stress hormones and physiological fitness in adolescent females with depressive symptoms - [Chanudda Nabkasorn1,2, Nobuyuki Miyai1, Anek Sootmongkol3, Suwanna Junprasert2, Hiroichi Yamamoto1, Mikio Arita4 and Kazuhisa Miyashita1]
Double-Blind Comparison of Addition of a Second Mood Stabilizer Versus an Antidepressant to an Initial Mood Stabilizer for Treatment of Patients With Bipolar Depression - [L. Trevor Young, M.D., Ph.D., Russell T. Joffe, M.D., Janine C. Robb, B.Sc.N., Glenda M. MacQueen, M.D., Ph.D., Michael Marriott, Ph.D. and Irene Patelis-Siotis, M.D.]
Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline - [R. M. POST, L. L. ALTSHULER, G. S. LEVERICH, M. A. FRYE, W. A. NOLEN,R.W. KUPKA, T. SUPPES, S. McELROY, P. E. KECK, K. D. DENICOFF,H. GRUNZE, J.WALDEN, C. M. R. KITCHEN and J. MINTZ]
Antidepressants for Bipolar Depression: A Systematic Review of Randomized, Controlled Trials - [Harm J. Gijsman, Ph.D., M.R.C.Psych., John R. Geddes, M.D., F.R.C.Psych., Jennifer M. Rendell, M.A., Willem A. Nolen, Ph.D. and Guy M. Goodwin, D.Phil., F.R.C.Psych.]
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression - [Gary S. Sachs, M.D., Andrew A. Nierenberg, M.D., Joseph R. Calabrese, M.D., Lauren B. Marangell, M.D., Stephen R. Wisniewski, Ph.D., Laszlo Gyulai, M.D., Edward S. Friedman, M.D., Charles L. Bowden, M.D., Mark D. Fossey, M.D., Michael J. Ostacher, M.D., M]
Modafinil Add-On in the Treatment of Bipolar Depression - [R. H. Belmaker, M.D.]
Mood-Incongruent Psychotic Features in Bipolar Disorder: Familial Aggregation and Suggestive Linkage to 2p11-q14 and 13q21-33 - [Fernando S. Goes, M.D., Peter P. Zandi, Ph.D., Kuangyi Miao, M.S., Francis J. McMahon, M.D., Jo Steele, B.Eng., Virginia L. Willour, Ph.D., Dean F. MacKinnon, M.D., Francis M. Mondimore, M.D., Barbara Schweizer, R.N., B.S., John I. Nurnberger Jr., , M.D.,]
Successful Tobacco Dependence Treatment in Schizophrenia - [Jill M. Williams, M.D. and Jonathan Foulds, Ph.D.]
Alcohol Use and Anxiety: Diagnostic and Management Issues - [Kathleen T. Brady, M.D., Ph.D., Bryan K. Tolliver, M.D., Ph.D. and Marcia L. Verduin, M.D.]
Early Psychosocial Intervention Following Traumatic Events - [Jonathan I. Bisson, D.M., F.R.C.Psych., Mark Brayne, M.A., Frank M. Ochberg, M.D. and George S. Everly Jr., Ph.D.]
Efficacy and Tolerability of Olanzapine, Quetiapine, and Risperidone in the Treatment of Early Psychosis: A Randomized, Double-Blind 52-Week Comparison - [Joseph P. McEvoy, M.D., Jeffrey A. Lieberman, M.D., Diana O. Perkins, M.D., M.P.H., Robert M. Hamer, Ph.D., Hongbin Gu, Ph.D., Arthur Lazarus, M.D., M.B.A., Dennis Sweitzer, Ph.D., Christina Olexy, Peter Weiden, M.D. and Stephen D. Strakowski, M.D.]
Relationship Between Antidepressants and Suicide Attempts: An Analysis of the Veterans Health Administration Data Sets - [Robert D. Gibbons, Ph.D., C. Hendricks Brown, Ph.D., Kwan Hur, Ph.D., Sue M. Marcus, Ph.D., Dulal K. Bhaumik, Ph.D. and J. John Mann, M.D.]
Connections in Schizophrenia - [Kelvin O. Lim, M.D.]
Cognition, Drug Treatment, and Functional Outcome in Schizophrenia: A Tale of Two Transitions - [Michael F. Green, Ph.D.]
Antidepressants and Suicidal Behavior: Cause or Cure? - [David Brent, M.D.]
Suicide Attempts Among Patients Starting Depression Treatment With Medications or Psychotherapy - [Gregory E. Simon, M.D., M.P.H. and James Savarino, Ph.D.]
Psychotherapy for bulimia nervosa and binging - [PJ Hay, J Bacaltchuk, S Stefano]
Family therapy for depression - [HT Henken, MJH Huibers, R Churchill, K Restifo, J Roelofs]
A Preliminary Study of Dopamine Transporter Binding in Bipolar and Unipolar Depressed Patients and Healthy Controls - [Jay D. Amsterdama, Andrew B. Newbergb]
Sleep paralysis and trauma, psychiatric symptoms and disorders in an adult African American population attending primary medical care - [Thomas A. Mellman, M.D., Notalelomwan Aigbogun, M.S., Ruth Elaine Graves, Ph.D., William B. Lawson, M.D., Ph.D., Tanya N. Alim, M.D.]
Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS): Demographic and Clinical Characteristics - [Frazier, Jean A.M.D.; McClellan, Jon M.D.; Findling, Robert L.M.D.; Vitiello, Benedetto M.D.; Anderson, Robert B.S.; Zablotsky, Benjamin B.A.; Williams, Emily M.Ed.; McNamara, Nora K.M.D.; Jackson, Joseph A.D.O.; Ritz, Louise M.B.A.; Hlastala, Stefanie A.]
Facial Emotion Processing in Acutely Ill and Euthymic Patients With Pediatric Bipolar Disorder - [Schenkel, Lindsay S.Ph.D.; Pavuluri, Mani N.M.D., Ph.D.; Herbener, Ellen S.Ph.D.; Harral, Erin M.B.A.; Sweeney, John A.Ph.D]
Association between BanI genotype and increased phospholipase A2 activity in schizophrenia - [Nadia R. Barbosa1, Ricardo M. Junqueira1, Homero P. Vallada1 and Wagner F. Gattaz1]
The influence of symptoms of prolonged grief disorder, depression, and anxiety on quality of life among bereaved adults : A prospective study - [Paul A. Boelen1 and Holly G. Prigerson2]
Neuropsychological performance in partly remitted unipolar depressive patients: focus on executive functioning - [Jens Westheide1, Michael Wagner1, Boris B. Quednow2, Christian Hoppe3, Déirdre]
Recognition and Management of Depression in a Substance Use Disorder Treatment Population - [G. M. Curran 1,2; B. M. Booth 1,2; J. E. Kirchner 1,2; D. E. Deneke 2]
Passiflora for anxiety disorder - [LS Miyasaka, AN Atallah, BGO Soares]
Psychostimulants for depression - [B Candy, L Jones, R William, A Tookman, M King]
A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders - [Susan L McElroya, Mark A Fryeb, Lori L Altshulerb, Trisha Suppesc, Gerhard Hellemannd, David Blacke, Jim Mintzd, Ralph Kupkaf, Willem Noleng, Gabriele S Leverichh, Kirk D Denicoffh, Robert M Posti, Paul E Keck Jra,j]
Measuring anxiety and depression in the oncology setting using visual-digital scales - [Erik Onel?v 1; Gunnar Steineck 1,2; Ullakarin Nyberg 1,3; Arna Hauksdóttir 1; Ulrika Kreicbergs 4,5; Lars Henningsohn 1,6; Karin Bergmark 1,7; Unnur Valdimarsdóttir 1,8]
Schizophrenia and Pathological Gambling - [Laurence Borras ; Philippe Huguelet]
Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS): Rationale, Design, and Methods - [McClellan, Jon M.D.; Sikich, Linmarie M.D.; Findling, Robert L.M.D.; Frazier, Jean A.M.D.; Vitiello, Benedetto M.D.; Hlastala, Stefanie A.Ph.D.; Williams, Emily M.Ed.; Ambler, Denisse M.D.; Hunt-Harrison, Tyehimba M.D.; Maloney, Ann E.M.D.; Ritz, Louise M]
Baseline Depressive Symptoms Predict Poor Substance Use Outcome Following Adolescent Residential Treatment - [Subramaniam, Geetha A.M.D.; Stitzer, Maxine A.Ph.D.; Clemmey, Philip Ph.D.; Kolodner, Ken Sc.D.; Fishman, Marc J.M.D]
Complicated grief after traumatic loss : A 14-month follow up study - [Anette Kersting1, K. Kroker1, J. Steinhard2, K. Lüdorff1, U. Wesselmann1, P. Ohrmann1, V. Arolt1 and T. Suslow1]
Depressive Symptoms and All-Cause Mortality After Heart Transplantation - [Havik, Odd E.1,4; Sivertsen, Borge1; Relbo, Anne2; Hellesvik, Marit2; Grov, Ingelin2; Geiran, Odd3; Andreassen, Arne K.2; Simonsen, Svein2; Gullestad, Lars2]
Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial - [Lenze EJ, Mulsant BH, Shear MK, Dew MA, Miller MD, Pollock BG, Houck P, Tracey B, Reynolds CF.]
Comparison of the Novel Antipsychotic Ziprasidone with Clozapine and Olanzapine: Inhibition of Dorsal Raphe Cell Firing and the Role of 5-HT1A Receptor Activation - [Jeffrey S Sprouse Ph.D, Linda S Reynolds MS, John P Braselton BS, Hans Rollema Ph.D and Stevin H Zorn Ph.D]
Effects of Serotonin (5-Hydroxytryptamine, 5-HT) Reuptake Inhibition Plus 5-HT2A Receptor Antagonism on the Firing Activity of Norepinephrine Neurons - [Szabo ST, Blier P.]
Repeated administration of the substituted amphetamine p-methoxyamphetamine produces reductions in cortical 5-HT transporter binding but not 5-HT content, unlike 3,4-methylenedioxyamethamphetamine - [Paul D. Callaghan, Kirsten Farrand, Abdallah Salem, Patrick Hughes, Lynette C. Daws and Rodney J. Irvine]
Inflammation and the pathophysiology of work-related musculoskeletal disorders - [Barbe MF, Barr AE]
Discontinuation reactions associated with SSRIs - [Macdonald, Lynn]
Bipolar Depression in Primary in primary care-A hidden threat - [Lewis FT.]
Pharmacologic treatment of depression in late life - [Alastair J Flint]
Comparing the Effects of Antidepressants: Consensus Guidelines for Evaluating Quantitative Reviews of Antidepressant Efficacy - [Jeffery A Lieberman1, Joel Greenhouse2, Robert M Hamer3, K Ranga Krishnan4, Charles B Nemeroff5, David V Sheehan6, Michael E Thase7 and Martin B Keller8]
Strain Differences in the Behavioral Effects of Antidepressant Drugs in the Rat Forced Swimming Test - [Carolina López-Rubalcava Ph.D and Irwin Lucki Ph.D]
Nicotinic acetylcholine receptors as targets for antidepressants - [R D Shytle1,2,3,4,5,6,7, A A Silver2,3, R J Lukas8, M B Newman1,6, D V Sheehan7 and P R Sanberg1,2,3,4,5,6,7]
The Effect of Early Poststressor Intervention with Sertraline on Behavioral Responses in an Animal Model of Post-Traumatic Stress Disorder - [Michael A Matar A1, Hagit Cohen1, Zeev Kaplan1 and Joseph Zohar2]
Factors associated with sexual dysfunction in men with HIV infection - [Richardson D, Lamba H, Goldmeier D, Nalabanda A, Harris JR.]
Regulatory Effects of Reboxetine Treatment Alone, or Following Paroxetine Treatment, on Brain Noradrenergic and Serotonergic Systems - [Georgianna G Gould1, Marie-Christine Pardon1, David A Morilak1 and Alan Frazer1,2]
Shifting emphasis from pharmacogenomics to theragnostics - [Vural Ozdemir, Bryn Williams-Jones, Stephen J Glatt, Ming T Tsuang, James B Lohr, Christopher Reist]
Pooled Analysis of Antidepressant Levels in Lactating Mothers, Breast Milk, and Nursing Infants - [Alicia M Weissman, Barcey T Levy, Arthur J Hartz, Suzanne Bentler, et al]
Nasal Wegener’s and skin sarcoid—a rare combination of two granulomatous diseases - [Kuttikat A, Saeed T, Chopra B, Chopra S, Chakravarty K.]
Effect of paroxetine on extracellular serotonin and dopamine levels in the prefrontal cortex - [Kazuhiko Nakayama]
Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus - [Jesús M. Míguez, Lucinda Paz-Vali?as, Isabel Míguez, Manuel Aldegunde]
Effects of Acute Tryptophan Depletion on Negative Symptoms and Smoking Topography in Nicotine-Dependent Schizophrenics and Nonpsychiatric Controls - [Brian Hitsman1, Bonnie Spring2,3, William Wolf3,4, Regina Pingitore2,3, John W Crayton3,5 and Donald Hedeker6]
Loss of Serotonin Transporter Protein after MDMA and Other Ring-Substituted Amphetamines - [Tao Xie1, Liqiong Tong1, Michael W McLane1, George Hatzidimitriou1, Jie Yuan1, Una McCann2 and George Ricaurte1]
Clinical and Physiological Consequences of Rapid Tryptophan Depletion - [Moore P, Landolt HP, Seifritz E, Clark C, Bhatti T, Kelsoe J, Rapaport M, Gillin JC.]
Antidepressant induced cholestasis: hepatocellular redistribution of multidrug resistant protein (MRP2). - [Milkiewicz P, Chilton AP, Hubscher SG, Elias E]
Paroxetine retards disease onset and progression in Huntingtin mutant mice - [Wenzhen Duan, MD, PhD 1 *, Zhihong Guo, MD 1, Haiyang Jiang, MD 1, Bruce Ladenheim, MS 2, Xiangru Xu, PhD 1, Jean Lud Cadet, MD 2, Mark P. Mattson, PhD 1 3 AD:1Laboratory of Neurosciences, National Institute on Aging Intramural Research Program2Molecular]
A Double-Blind Study of Paroxetine, Fluoxetine, and Placebo an Outpatients with Major Depression - [.Maurizio Fava, M.D.,1,6 Jay D. Amsterdam, M.D.2, Joseph A. Deltito, M.D.,3 Carl Salzman, M.D.,4 Michael Schwaller, M.D.,5 and David L. Dunner, M.D.5]
Latency to paroxetine-induced anxiolysis in the rat is reduced by co-administration of the 5-HT1A receptor antagonist WAY100635 - [M S Duxon, K R Starr, N Upton]
Gene-environment interaction analysis of serotonin system markers with adolescent depression - [T C Eley1, K Sugden1, A Corsico1, A M Gregory1, P Sham1, P McGuffin1, R Plomin1 and I W Craig1]
A novel amyloidogenic transthyretin variant, Gly53Ala, associated with intermittent headaches and ataxia - [Douglass C, Suvarna K, Reilly MM, Hawkins PN, Hadjivassiliou M.]
Life-threatening serotonin syndrome in a patient with chronic heart failure and CYP2D6*1/*5. - [Sato A, Okura Y, Minagawa S, Ohno Y, Fujita S, Kondo D, Hayashi M, Komura S, Kato K, Hanawa H, Kodama M, Aizawa Y]
Serotonin transporter in substance P (neurokinin 1) receptor knock-out mice - [Boni, Stephen P. Hunt, Carmen De Felipe, Michel Hamon, Christian Jacquot, et al.]
Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disorders - [A Serretti1, P N Malitas2, L Mandelli1, C Lorenzi1, C Ploia1, B Alevizos2, C Nikolaou2, F Boufidou2, G N Christodoulou2 and E Smeraldi1]
Differential effects of chronic antidepressant treatments on μ- and δ-opioid receptors in rat brain - [Catherine Vilpoux, Céline Carpentier, Isabelle Leroux-Nicollet, Laurent Naudon and Jean Costentin]
Predicting treatment-outcome in cocaine dependence from admission urine drug screen and peripheral serotonergic measures - [Ashwin A. Patkar, Charles C. Thornton, Wade H. Berrettini, Edward Gottheil, Stephen P. Weinstein and Kevin P. Hill]
The effects of a 5-hydroxytryptamine 1A receptor gene polymorphism on the clinical response to fluvoxamine in depressed patients - [Y Suzuki1, K Sawamura1 and T Someya1]
Dopamine depletion abolishes apomorphine- and amphetamine-induced increases in extracellular serotonin levels in the striatum of conscious rats: a microdialysis study - [A. Balcioglu, K. Zhang and F. I. Tarazi]
Effects of paroxetine on heart period variability in patients with panic disorder: a study of holter ECG records. - [Yeragani VK, Jampala VC, Sobelewski E, Kay J, Igel G]
分页: 1 2 3 4 5 6 7 [8] 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
41 42 43 44 45 46 47 48 49 50 |